The Vaccine and Infectious Disease Division of Fred Hutch Cancer Center is seeking a visionary scientific leader to accelerate discoveries in infectious diseases and immunology that can transform approaches to prevention, treatment and cure of human infectious diseases of public health importance.
This Bezos Family Distinguished Scholar in Viruses and Vaccines position is supported by the Bezos family’s transformative gift that was announced in 2022. The position may include leadership opportunities for the Division, associated programs and new scientific directions, depending on the interests and qualifications of the candidate and needs of the Division. This position will include generous startup funds, an endowed chair, funding for internal and external collaborations, and support for additional faculty recruitment.
The Vaccine and Infectious Disease Division (VIDD) is a global leader in clinical, laboratory, and epidemiological research, focusing on major public health challenges, including cancer-related issues. With a multidisciplinary team of over 600 experts, VIDD operates three research programs in Biostatistics, Bioinformatics and Epidemiology; Immunology and Vaccine Development; and Infectious Disease Science. VIDD excels in translational science, integrating expertise across basic, translational, and clinical research to prevent, treat, and cure infectious diseases like SARS-CoV-2, HIV, herpesviruses, influenza, tuberculosis, malaria, and other respiratory infections.
VIDD conducts basic research together with observational infectious disease cohort studies, advanced human immunology research, and discovery medicine. VIDD also carries out first-in-human to advanced stage prevention and treatment studies, and is the headquarters of the HIV Vaccine Trials Network Leadership Centers. The Division is at the forefront of developing pathogen challenge models, including those for malaria and BCG, and investigating pathogens associated with cancer and other critical global health issues.
The successful candidate will possess demonstrated leadership, creativity, passion and international recognition in their ability to direct innovative basic, translational, and/or clinical collaborative research in infectious diseases of global health importance.
This appointment will be at the rank of a full-time full professor, with primary appointment in the Vaccine and Infectious Disease Division at Fred Hutch Cancer Center. A potential joint appointment may be considered at the University of Washington Department of Medicine and/or other relevant departments at the University of Washington School of Medicine.
Fred Hutch Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington state.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities makes us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.